Altre lingue ImmuCell Corporation

Azioni

ICCC

US4525253062

Tempo differito Nasdaq Altri mercati azionari 18:07:41 15/05/2024			Variaz. 5gg	Var. 1 gen.
4,95 ^USD	-9,61%		-5,71%	-2,75%

15:00	Transcript : ImmuCell Corporation, Q1 2024 Earnings Call, May 15, 2024
02/04	Le azioni di ImmuCell calano dopo il deposito di titoli misti da 20 milioni di dollari	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

ImmuCell : May 2024 Corporate Presentation	14/05
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024	14/05
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024	08/05
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024	09/04
Immucell Corporation Reports Unaudited Sales Results for the Three Months and Twelve Months Ended March 31, 2024	09/04
ImmuCell Shares Fall After $20 Million Mixed Securities Shelf Filing	02/04
ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023	27/02
ImmuCell Corporation Enters into an Allonge to and Amendment of Line of Credit with Gorham Savings Bank	27/02
ImmuCell Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	27/02
ImmuCell Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	27/02
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023	16/02
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023	08/01
ImmuCell Corporation Announces Unaudited Sales Results for the Fourth Quarter and Full Year Ended December 31, 2023	08/01
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023	13/11
ImmuCell Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023	07/11
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023	05/10/23
Immucell Corporation Reports Preliminary Unaudited Sales Results for the Third Quarter, Nine Months and Trailing Twelve Months Ended September 30, 2023	05/10/23
ImmuCell Announces Submission of CMC Technical Section to the FDA	29/08/23
ImmuCell : August 2023 Corporate Presentation	10/08/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue ImmuCell Corporation

Azioni

ICCC

US4525253062

Altre lingue

Filtri